cbdMD (YCBD) Current Deferred Revenue (2017 - 2025)
cbdMD (YCBD) reported Current Deferred Revenue of $488626.0 for Q4 2025, down 7.36% on a YoY basis from $527438.0 in Q4 2024, and down 3.49% sequentially from $506289.0 in Q3 2025.
cbdMD (YCBD) Current Deferred Revenue (2017 - 2025) Analysis & Trends
cbdMD (YCBD) has 8 years of Current Deferred Revenue data on file, last reported at $488626.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue fell 7.36% year-over-year to $488626.0; the trailing twelve-month figure through Dec 2025 stood at $488626.0 (down 7.36% YoY), and the FY2025 full-year result was $506289.0, up 0.6% from the prior year.
- Current Deferred Revenue fell to $488626.0 in Q4 2025, from $506289.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $557353.0 in Q1 2025 to a low of $755.0 in Q2 2021.
- A 4-year average of $429667.4 and a median of $504771.5 in 2024 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue surged 171.67% in 2024 and dropped 7.43% in 2025, its largest moves.
- Tracing YCBD's Current Deferred Revenue over 4 years: stood at $755.0 in 2021, then jumped by 24435.89% to $185246.0 in 2023, then jumped by 184.72% to $527438.0 in 2024, then dropped by 7.36% to $488626.0 in 2025.
- Business Quant data shows YCBD's Current Deferred Revenue at $488626.0 in Q4 2025, $506289.0 in Q3 2025, and $509198.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | cbdMD | 4.60 Mn | 1.22 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 488,626.00 |
| Sep 30, 2025 | 506,289.00 |
| Jun 30, 2025 | 509,198.00 |
| Mar 31, 2025 | 557,353.00 |
| Dec 31, 2024 | 527,438.00 |
| Sep 30, 2024 | 503,254.00 |
| Jun 30, 2024 | 550,043.00 |
| Mar 31, 2024 | 468,472.00 |
| Sep 30, 2023 | 185,246.00 |
| Jun 30, 2021 | 755.00 |
| Dec 31, 2020 | 22,440.00 |
| Jun 30, 2019 | 4,585.00 |
| Mar 31, 2019 | 33,333.00 |
| Dec 31, 2018 | 47,083.00 |
| Sep 30, 2018 | 161,458.00 |
| Jun 30, 2018 | 163,333.00 |
| Mar 31, 2018 | 120,625.00 |
| Dec 31, 2017 | 49,125.00 |
| Sep 30, 2017 | 41,417.00 |